22nd Century Invited to Speak at the Colorado Hemp Expo about the Company’s Medical Marijuana Initiatives & Zero-THC Hemp P...
March 29 2017 - 9:45AM
Business Wire
22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco
harm reduction and cannabis research, announced today that
representatives of the Company’s wholly-owned subsidiary, Botanical
Genetics, have been invited to serve as featured speakers and
presenters at the annual Colorado Hemp Expo at the Ranch Events
Complex, 5260 Arena Circle, Loveland, Colorado on Friday, March 31,
2017, and Saturday, April 1, 2017.
Dr. Paul Rushton, Vice President of Plant Biotechnology, and
Thomas James, Esq., Vice President & General Counsel, will
provide conference attendees with business and scientific updates
and highlights of 22nd Century’s advances in the rapidly evolving
legal medical marijuana and industrial hemp markets. Headlining the
presentation will be Dr. Rushton’s featured speech on Friday
evening regarding the Company’s proprietary cannabis initiatives,
including the Company’s recently announced development of THC-free
industrial hemp plants and the propagation of medical marijuana
strains that are selected for increased levels of
medically-important cannabinoids, such as CBC and CBD. Dr. Rushton
will also speak in a panel discussion on Seeds, Clones, Pesticides
and Pollen at the conference. Mr. James will speak on three panel
discussions: Investments in Hemp, Global Hemp Activities, and The
Future of Hemp. Dr. Rushton, Mr. James and other representatives of
the Company will be available for one-on-one meetings throughout
the conference.
“We are developing several exciting new strains of medical
marijuana as well as industrial hemp varieties with substantially
altered levels of cannabinoids – all of which will be below the
legal limit of 0.3% THC,” explained Dr. Rushton. “Following our
recently announced success with Zero-THC hemp plants and our major
collaboration with the University of Virginia, Botanical Genetics
is now aggressively expanding our activities in an effort to make
our Company a major source of proprietary plants for both the legal
medical marijuana and industrial hemp markets. We look forward to
exploring exciting business opportunities with like-minded
companies in Colorado.”
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on
technology which allows us to increase or decrease the level of
nicotine in tobacco plants and the level of cannabinoids in
cannabis plants through genetic engineering and plant breeding. The
Company’s primary mission in tobacco is to reduce the harm caused
by smoking. The Company’s primary mission in cannabis is to develop
proprietary cannabis strains for important new medicines and
agricultural crops. 22nd Century currently owns or exclusively
controls more than 200 issued patents and more than 50 pending
patent applications around the world. For more information, visit
www.xxiicentury.com and www.botanicalgenetics.com.
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release, including but not limited to our future revenue
expectations. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
fiscal year ended December 31, 2016, filed on March 8, 2017,
including the section entitled “Risk Factors,” and our other
reports filed with the U.S Securities and Exchange Commission which
attempt to advise interested parties of the risks and factors that
may affect our business, financial condition, results of operation
and cash flows. If one or more of these risks or uncertainties
materialize, or if the underlying assumptions prove incorrect, our
actual results may vary materially from those expected or
projected.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170329005319/en/
22nd Century Group, Inc.Investor Relations:IRTH
CommunicationsAndrew Haag,
866-976-4784xxii@irthcommunications.com
22nd Century (AMEX:XXII)
Historical Stock Chart
From Mar 2024 to Apr 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2023 to Apr 2024